All-Time-High Stocks: Healthcare Sector Cannot be Ignored!

Yesterday, $NVIDIA Corp(NVDA)$ hit another all-time high, achieving a 135% YTD increase. Besides the highly sought-after NVDA in the market, these companies also reached new highs yesterday.

  • $Eli Lilly(LLY)$ is a global pharmaceutical company focused on developing innovative medicines for serious diseases.

  • $Novo-Nordisk A/S(NVO)$ is a leading global healthcare company specializing in diabetes care and other chronic diseases.

$Eli Lilly(LLY)$ and $Novo-Nordisk A/S(NVO)$ surged due to the booming popularity of weight-loss drugs.

After achieving over 50% growth last year, they have risen more than 35% this year. The weight-loss drug sector may not be as alluring as AI, but it is considered a safe play.

  • $Costco(COST)$ operates a global chain of membership-only warehouse clubs. COST has been continuously climbing over the past two years, reaching $800, and is likely to be the next company to split its stock.

  • $McKesson(MCK)$ is a major American pharmaceutical distributor and healthcare information technology company.

  • $Royal Caribbean Cruises(RCL)$ is a global cruise vacation company that owns and operates several cruise brands. The robust consumer demand and pricing power are reflected in its growing gross profit margins

Which stock do you favor most?

# Market Pullback Begins? Sell or Hedge?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet